Buy Full Version
"Global Infection Prevention & Enteral Access Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Global Infection Prevention & Enteral Access Market by Product (Enteral Feeding Pumps, Enteral Feeding Tubes, Administration Reservoirs, Giving Sets, and Enteral Syringes), Age (Adults and Pediatrics), End User (Hospitals and Ambulatory Care Services), and Application (Oncology, Gastroenterology, Diabetes, Neurological Disorders, and Hypermetabolism) - Opportunity Analysis and Industry Forecast, 2019-2026

Medical Devices & Supplies	LI_184180	Pages: NA	Jan 2020 \| 809 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Enteral access is the process by which nutrition is delivered to the patient. It is usually used in hospitalized patients; in this process, liquid supplements or daily requirements are fed to the patient with the help of a tube.

Factors such as presence of postoperative patients with limited oral intake, increasing incidences of severe pancreatitis & chronic diseases, increasing geriatric population, technological advancements, and higher immature births drive the market growth. However, complications associated with these devices and reimbursement issues in developing countries restrain the market growth. Moreover, increasing R&D investments and untapped market opportunities in developing countries increase opportunities for the market growth.

The infection prevention & enteral access market is segmented on the basis of product, age, end user, application, and region. On the basis of product, it is segmented into enteral feeding pumps, enteral feeding tubes, administration reservoirs, giving sets, enteral syringes, and others. On the basis of age, it is segmented into adults and pediatrics. On the basis of end user it is segmented into hospitals, ambulatory care services, and others. On the basis of application it is segmented into oncology, gastroenterology, diabetes, neurological disorders, hypermetabolism, and others. Geographically, the market has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players in the market include Cook Medical Inc., Medtronic plc, Boston Scientific Corporation, CONMED Corporation, CORPAK MedSystems., CR Bard, Inc, ALCOR Scientific Inc., Pacific Hospital Supply Co., Ltd, Teleflex Incorporated, and Vygon SA.

Key Benefits

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
It offers a quantitative analysis from 2016 to 2023, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
Extensive analysis by product helps understand various types of products used for enteral access.
Comprehensive analysis of all geographical regions has been provided, which helps determine prevailing opportunities.
Key players have been profiled and their strategies thoroughly analyzed, which helps understand the competitive outlook of the global market.

Global Infection Prevention & Enteral Access Market Key Segments:

By Product

Enteral Feeding Pumps
Enteral Feeding Tubes
- Nasoenteric Feeding Tubes
  - Nasogastric Feeding Tubes
  - Nasoduodenal Feeding Tubes
  - Nasojejunal Feeding Tubes
- Oroenteric Feeding Tubes
- Enterostomy Tubes
  - Standard Tubes
    - Gastrostomy Tubes
    - Jejunostomy Tubes
    - Gastrojejunostomy Tubes
  - Low Profile Tubes
- Others
Administration Reservoirs
Giving Sets
Enteral Syringes
Others

By Age

Adults
Pediatrics

By End User

Hospitals
Ambulatory Care Services
Others

By Application

Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

CHAPTER 4 GLOBAL INFECTION PREVENTION & ENTERAL ACCESS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ENTERAL FEEDING PUMPS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ENTERAL FEEDING TUBES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Nasoenteric Feeding Tubes

4.3.3.1.1. Market size and forecast
4.3.3.1.2. Nasogastric Feeding Tubes

4.3.3.1.2.1. Market size and forecast

4.3.3.1.3. Nasoduodenal Feeding Tubes

4.3.3.1.3.1. Market size and forecast

4.3.3.1.4. Nasojejunal Feeding Tubes

4.3.3.1.4.1. Market size and forecast

4.3.3.2. Oroenteric Feeding Tubes

4.3.3.2.1. Market size and forecast

4.3.3.3. Enterostomy Tubes

4.3.3.3.1. Market size and forecast
4.3.3.3.2. Standard Tubes

4.3.3.3.2.1. Market size and forecast
4.3.3.3.2.2. Gastrostomy Tubes

4.3.3.3.2.2.1. Market size and forecast

4.3.3.3.2.3. Jejunostomy Tubes

4.3.3.3.2.3.1. Market size and forecast

4.3.3.3.2.4. Gastrojejunostomy Tubes

4.3.3.3.2.4.1. Market size and forecast

4.3.3.3.3. Low Profile Tubes

4.3.3.3.3.1. Market size and forecast

4.3.3.4. Others

4.3.3.4.1. Market size and forecast

4.4. ADMINISTRATION RESERVOIRS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. GIVING SETS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. ENTERAL SYRINGES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHERS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

CHAPTER 5 GLOBAL INFECTION PREVENTION & ENTERAL ACCESS MARKET, BY AGE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ADULTS

5.2.1. Market size and forecast

5.3. PEDIATRICS

5.3.1. Market size and forecast

CHAPTER 6 GLOBAL INFECTION PREVENTION & ENTERAL ACCESS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY CARE SERVICES

6.3.1. Market size and forecast

6.4. OTHERS

6.4.1. Market size and forecast

CHAPTER 7 GLOBAL INFECTION PREVENTION & ENTERAL ACCESS MARKET, BY APPLICATION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. ONCOLOGY

7.2.1. Market size and forecast

7.3. GASTROENTEROLOGY

7.3.1. Market size and forecast

7.4. DIABETES

7.4.1. Market size and forecast

7.5. NEUROLOGICAL DISORDER

7.5.1. Market size and forecast

7.6. HYPERMETABOLISM

7.6.1. Market size and forecast

7.7. OTHERS

7.7.1. Market size and forecast

CHAPTER 8 GLOBAL INFECTION PREVENTION & ENTERAL ACCESS MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.2.4. North America Infection Prevention & Enteral Access Market, by Product
8.2.5. North America Infection Prevention & Enteral Access Market, by Age
8.2.6. North America Infection Prevention & Enteral Access Market, by End User
8.2.7. North America Infection Prevention & Enteral Access Market, by Application

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.3.4. Europe Infection Prevention & Enteral Access Market, by Product
8.3.5. Europe Infection Prevention & Enteral Access Market, by Age
8.3.6. Europe Infection Prevention & Enteral Access Market, by End User
8.3.7. Europe Infection Prevention & Enteral Access Market, by Application

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. India market size and forecast
8.4.3.4. Rest of Asia-Pacific market size and forecast

8.4.4. Asia-Pacific Infection Prevention & Enteral Access Market, by Product
8.4.5. Asia-Pacific Infection Prevention & Enteral Access Market, by Age
8.4.6. Asia-Pacific Infection Prevention & Enteral Access Market, by End User
8.4.7. Asia-Pacific Infection Prevention & Enteral Access Market, by Application

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast

8.5.4. LAMEA Infection Prevention & Enteral Access Market, by Product
8.5.5. LAMEA Infection Prevention & Enteral Access Market, by Age
8.5.6. LAMEA Infection Prevention & Enteral Access Market, by End User
8.5.7. LAMEA Infection Prevention & Enteral Access Market, by Application

CHAPTER 9 COMPANY PROFILES

9.1. COOK MEDICAL INC.

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. MEDTRONIC PLC

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. BOSTON SCIENTIFIC CORPORATION

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. CONMED CORPORATION

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. CORPAK MEDSYSTEMS

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. CR BARD, INC

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. ALCOR SCIENTIFIC INC.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. PACIFIC HOSPITAL SUPPLY CO. LTD.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. TELEFLEX INCORPORATED

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. VYGON SA

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com